| Increased adiposity in animals due to a human virus NV Dhurandhar, BA Israel, JM Kolesar, GF Mayhew, ME Cook, ... International journal of obesity 24 (8), 989-996, 2000 | 319 | 2000 |
| Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study SJ Lubner, MR Mahoney, JL Kolesar, NK LoConte, GP Kim, HC Pitot, ... Journal of Clinical Oncology 28 (21), 3491-3497, 2010 | 316 | 2010 |
| Pharmacotherapy principles & practice MA Edited by Chisholm-Burns, PM Malone, TL Schwinghammer, ... McGraw-Hill Education, 2016 | 281 | 2016 |
| Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial A Argiris, M Ghebremichael, J Gilbert, JW Lee, K Sachidanandam, ... Journal of Clinical Oncology 31 (11), 1405-1414, 2013 | 228 | 2013 |
| A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone … C Sweeney, G Liu, C Yiannoutsos, J Kolesar, D Horvath, MJ Staab, K Fife, ... Clinical cancer research 11 (18), 6625-6633, 2005 | 218 | 2005 |
| Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14. 18-IL2 immunotherapy DC Delgado, JA Hank, J Kolesar, D Lorentzen, J Gan, S Seo, KM Kim, ... Cancer research 70 (23), 9554-9561, 2010 | 199 | 2010 |
| A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer L Van Ummersen, K Binger, J Volkman, R Marnocha, K Tutsch, J Kolesar, ... Clinical Cancer Research 10 (22), 7450-7456, 2004 | 191 | 2004 |
| Phase I trial of a monoclonal antibody specific for αvβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion DG McNeel, J Eickhoff, FT Lee, DM King, D Alberti, JP Thomas, A Friedl, ... Clinical Cancer Research 11 (21), 7851-7860, 2005 | 190 | 2005 |
| Transmissibility of adenovirus-induced adiposity in a chicken model NV Dhurandhar, BA Israel, JM Kolesar, G Mayhew, ME Cook, RL Atkinson International journal of obesity 25 (7), 990-996, 2001 | 164 | 2001 |
| Vorinostat (NSC# 701852) in patients with relapsed non-small cell lung cancer: a Wisconsin Oncology Network phase II study AM Traynor, S Dubey, JC Eickhoff, JM Kolesar, K Schell, MS Huie, ... Journal of Thoracic Oncology 4 (4), 522-526, 2009 | 156 | 2009 |
| Potential utility of liquid biopsy as a diagnostic and prognostic tool for the assessment of solid tumors: implications in the precision oncology RA Mathai, RVS Vidya, BS Reddy, L Thomas, K Udupa, J Kolesar, M Rao Journal of clinical medicine 8 (3), 373, 2019 | 151 | 2019 |
| A 3-in-1 polymeric micelle nanocontainer for poorly water-soluble drugs HC Shin, AWG Alani, H Cho, Y Bae, JM Kolesar, GS Kwon Molecular pharmaceutics 8 (4), 1257-1265, 2011 | 146 | 2011 |
| Lapatinib: A small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor—2 tyrosine kinases used in the treatment of breast cancer AJ Tevaarwerk, JM Kolesar Clinical therapeutics 31, 2332-2348, 2009 | 142 | 2009 |
| Opportunities for drug repositioning from phenome-wide association studies M Rastegar-Mojarad, Z Ye, JM Kolesar, SJ Hebbring, SM Lin Nature biotechnology 33 (4), 342-345, 2015 | 132 | 2015 |
| A phase II trial of Triapine®(NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503 AM Traynor, JW Lee, GK Bayer, JM Tate, SP Thomas, M Mazurczak, ... Investigational new drugs 28, 91-97, 2010 | 122 | 2010 |
| Prevention and treatment of chemotherapy-induced peripheral neuropathy J Piccolo, JM Kolesar American journal of health-system pharmacy 71 (1), 19-25, 2014 | 118 | 2014 |
| Vorinostat: A novel therapy for the treatment of cutaneous T-cell lymphoma SA Kavanaugh, LA White, JM Kolesar American journal of health-system pharmacy 67 (10), 793-797, 2010 | 116 | 2010 |
| A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients E Messing, JR Gee, DR Saltzstein, KM Kim, A diSant'Agnese, J Kolesar, ... Cancer prevention research 5 (4), 621-630, 2012 | 108 | 2012 |
| Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer AM Traynor, JH Schiller, LP Stabile, JM Kolesar, JC Eickhoff, S Dacic, ... Lung cancer 64 (1), 51-59, 2009 | 107 | 2009 |
| Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma JJ Hiles, JM Kolesar American Journal of Health-System Pharmacy 65 (2), 123-131, 2008 | 103 | 2008 |
Susanne Arnold, MDMarkey Cancer Center University of Kentucky在 uky.edu 的电子邮件经过验证
